Figures & data
Notes: HPLC fingerprint of the herbal formula B401. Characteristic peaks of B401, ie, (Aa) ginsenosides Rb1 (from Panax ginseng) and oleanolic acid (from Ligustri fructus), (Ab) formononetin (from Astragalus membranaceus), (Ac) 5-HMF (from Rehmannia glutinosa), (Ad) ferulic acid (from L. fructus), (Ae) wedelolactone (from Eclipta prostrata), were identified and marked at the corresponding peaks in the fingerprint. (B) Cell viabilities of RA-induced SH-SY5Y cells in the absence (Ctrl) or presence of the B401 at indicated doses. The herbal formula B401 has no cytotoxicity in SH-SY5Y cells under treatment at a dose of less than 80 mg/mL.
Abbreviations: AU, arbitrary unit; IC50, half maximal inhibitory concentration; 5-HMF, 5-hydroxymethylfurfural; RA, retinoic acid; Ctrl, control group.
Abbreviations: AU, arbitrary unit; IC50, half maximal inhibitory concentration; 5-HMF, 5-hydroxymethylfurfural; RA, retinoic acid; Ctrl, control group.
Notes: (A) Gait analysis of 10-week-old R6/2 mice given the oral B401 and sham treatments. (B) Averaged stride lengths of paw placement records of the 10-week-old R6/2 mice given the oral B401 treatment were significantly better than those given the sham treatment. The number of R6/2 mice under oral B401 and sham treatments were eight for each group. Values are mean ± SEM (**P<0.01, one-way ANOVA followed by a Student–Newman–Keuls multiple comparisons posttest).
Abbreviations: HD, Huntington’s disease; ANOVA, analysis of variance; SEM, standard error of the mean.
Abbreviations: HD, Huntington’s disease; ANOVA, analysis of variance; SEM, standard error of the mean.
Notes: (A) IHC staining shows that the expressions of huntingtin in the striatum, hippocampus, and medulla of the 10-week-old R6/2 mice given the oral B401 treatment were obviously weaker than those given the sham treatment but were obviously more intense than their WT. Scale bars: 30 µm. Western blotting analysis shows the following: (Ba) expression levels of huntingtin in whole brain tissue of the 10-week-old R6/2 mice given both the oral B401 and sham treatments, and their WT and (Bb) a significant increase in quantified brain huntingtin levels in the 10-week-old R6/2 mice in comparison with their WT, and a significant reduction under oral B401 treatment. The number of R6/2 mice under oral B401 and sham treatments and their WT was six for each group. Values are mean ± SEM (*P<0.05, **P<0.01, two-way ANOVA followed by a Student–Newman–Keuls multiple comparison posttest).
Abbreviations: HD, Huntington’s disease; IHC, immunohistochemistry; WT, wild-type littermate; ANOVA, analysis of variance; SEM, standard error of the mean.
Abbreviations: HD, Huntington’s disease; IHC, immunohistochemistry; WT, wild-type littermate; ANOVA, analysis of variance; SEM, standard error of the mean.
Notes: (A) IHC staining shows that the expressions of SOD2 in the striatum, hippocampus, and medulla of the 10-week-old R6/2 mice given the oral B401 treatment were obviously more intense than those given the sham treatment but were obviously weaker than their WT. Scale bars: 30 µm. Western blotting analysis shows the following: (Ba) expression levels of SOD2 in whole brain tissue of the 10-week-old R6/2 mice given both oral B401 and sham treatments, and their WT and (Bb) quantified brain SOD2 levels of the 10-week-old R6/2 mice were significantly lower than their WT and significantly higher under oral B401 treatment. The number of R6/2 mice under oral B401 and sham treatments and their WT was six for each group. Values are mean ± SEM (**P<0.01, two-way ANOVA followed by a Student–Newman–Keuls multiple comparison posttest).
Abbreviations: HD, Huntington’s disease; IHC, immunohistochemistry; SOD2, superoxide dismutase 2; WT, wild-type littermate; ANOVA, analysis of variance; SEM, standard error of the mean.
Abbreviations: HD, Huntington’s disease; IHC, immunohistochemistry; SOD2, superoxide dismutase 2; WT, wild-type littermate; ANOVA, analysis of variance; SEM, standard error of the mean.
Notes: (A) IHC staining shows that the expressions of caspase 3 in the striatum, hippocampus, and medulla of 10-week-old R6/2 mice with oral B401 treatment were obviously weaker than those given the sham treatment but had shown no difference in their WT. Scale bars: 30 µm. Western blotting analysis shows the following: (Ba) expression levels of caspase 3 in whole brain tissue of the 10-week-old R6/2 mice given both oral B401 and sham treatments, and their WT and (Bb) quantified brain pro-caspase 3 (35 kDa) and cleaved caspase 3 (17 kDa) levels of the 10-week-old R6/2 mice were significantly higher than their WT and significantly lower under oral B401 treatment. The number of R6/2 mice under oral B401 and sham treatments and their WT was six for each group. Values are mean ± SEM (**P<0.01, two-way ANOVA followed by a Student–Newman–Keuls multiple comparison posttest).
Abbreviations: HD, Huntington’s disease; IHC, immunohistochemistry; WT, wild-type littermate; ANOVA, analysis of variance; SEM, standard error of the mean.
Abbreviations: HD, Huntington’s disease; IHC, immunohistochemistry; WT, wild-type littermate; ANOVA, analysis of variance; SEM, standard error of the mean.